An atlas of human vector-borne microbe interactions reveals pathogenicity mechanisms

Thomas M Hart1, Nicole D Sonnert2, Xiaotian Tang1

  • 1Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.

Cell
|June 14, 2024
PubMed

Insights

This study maps pathogen interactions with human proteins to understand vector-borne diseases. It reveals new targets for developing next-generation therapeutics against infectious diseases.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Background:

  • Vector-borne diseases cause significant global mortality, highlighting an unmet medical need.
  • Host-pathogen interactions at the extracellular protein level are critical in disease development.

Purpose of the Study:

  • To create a comprehensive atlas of microbial interactions with the human exoproteome.
  • To identify potential molecular targets for novel therapeutic strategies against vector-borne pathogens.

Main Methods:

  • Utilized bacterial selection to elucidate host-microbe interactions in high throughput (BASEHIT).
  • Interrogated interactions between 82 human-pathogen samples and 3,324 human exoproteins.
  • Conducted functional investigations on identified interactions.

Main Results:

  • Generated an atlas of 1,303 putative host-pathogen interactions.
  • Identified hundreds of interactions potentially involved in cell invasion, colonization, immune evasion, and host sensing.
  • Discovered that Lyme disease spirochetes use epidermal growth factor for transcriptional regulation and that pathogen-thioredoxin interactions aid cell invasion.

Conclusions:

  • The interactome atlas provides molecular insights into microbial pathogenesis.
  • Identified potential host-directed targets for next-generation therapeutics against vector-borne diseases.